BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 29526814)

  • 1. Integrating chemical, toxicological and clinical research to assess the potential of reducing health risks associated with cigarette smoking through reducing toxicant emissions.
    McAdam K; Murphy J; Eldridge A; Meredith C; Proctor C
    Regul Toxicol Pharmacol; 2018 Jun; 95():102-114. PubMed ID: 29526814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in levels of biomarkers of exposure and biological effect in a controlled study of smokers switched from conventional cigarettes to reduced-toxicant-prototype cigarettes.
    Shepperd CJ; Newland N; Eldridge A; Haswell L; Lowe F; Papadopoulou E; Camacho O; Proctor CJ; Graff D; Meyer I
    Regul Toxicol Pharmacol; 2015 Jul; 72(2):273-91. PubMed ID: 25957570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in tobacco and mainstream smoke toxicant yields from selected commercial cigarette products.
    Eldridge A; Betson TR; Gama MV; McAdam K
    Regul Toxicol Pharmacol; 2015 Apr; 71(3):409-27. PubMed ID: 25620723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of novel tobacco heating product THP1.0. Part 3: Comprehensive chemical characterisation of harmful and potentially harmful aerosol emissions.
    Forster M; Fiebelkorn S; Yurteri C; Mariner D; Liu C; Wright C; McAdam K; Murphy J; Proctor C
    Regul Toxicol Pharmacol; 2018 Mar; 93():14-33. PubMed ID: 29080848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of behavioural, chemical, toxicological and clinical studies of a tobacco heated product glo™ and the potential for bridging from a foundational dataset to new product iterations.
    Goodall S; Gale N; Thorne D; Hadley S; Prasad K; Gilmour I; Miazzi F; Proctor C
    Toxicol Rep; 2022; 9():1426-1442. PubMed ID: 36561950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Existing technologies to reduce specific toxicant emissions in cigarette smoke.
    O'Connor RJ; Hurley PJ
    Tob Control; 2008 Sep; 17 Suppl 1():i39-48. PubMed ID: 18768458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of aqueous aerosol extract (AqE) generation from e-cigarettes and tobacco heating products for in vitro cytotoxicity testing.
    Bozhilova S; Baxter A; Bishop E; Breheny D; Thorne D; Hodges P; Gaça M
    Toxicol Lett; 2020 Dec; 335():51-63. PubMed ID: 33091563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact assessment of WHO TobReg proposals for mandated lowering of selected mainstream cigarette smoke toxicants.
    Eldridge AC; McAdam KG; Betson TR; Gama MV; Proctor CJ
    Regul Toxicol Pharmacol; 2017 Jun; 86():332-348. PubMed ID: 28284711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches for the design of reduced toxicant emission cigarettes.
    Dittrich DJ; Fieblekorn RT; Bevan MJ; Rushforth D; Murphy JJ; Ashley M; McAdam KG; Liu C; Proctor CJ
    Springerplus; 2014; 3():374. PubMed ID: 25110628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in levels of biomarkers of exposure observed in a controlled study of smokers switched from conventional to reduced toxicant prototype cigarettes.
    Shepperd CJ; Eldridge A; Camacho OM; McAdam K; Proctor CJ; Meyer I
    Regul Toxicol Pharmacol; 2013 Jun; 66(1):147-62. PubMed ID: 23537587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of a novel tobacco-substitute sheet and smoke dilution to reduce toxicant yields in cigarette smoke.
    McAdam KG; Gregg EO; Liu C; Dittrich DJ; Duke MG; Proctor CJ
    Food Chem Toxicol; 2011 Aug; 49(8):1684-96. PubMed ID: 21501648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scope for regulation of cigarette smoke toxicity according to brand differences in published toxicant emissions.
    Laugesen M; Fowles J
    N Z Med J; 2005 Apr; 118(1213):U1401. PubMed ID: 15843830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of reducing the nicotine content of cigarettes on cigarette smoking behavior and tobacco smoke toxicant exposure: 2-year follow up.
    Benowitz NL; Nardone N; Dains KM; Hall SM; Stewart S; Dempsey D; Jacob P
    Addiction; 2015 Oct; 110(10):1667-75. PubMed ID: 26198394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro toxicological evaluation of a tobacco heating product THP COO and 3R4F research reference cigarette on human lung cancer cells.
    Wang H; Chen H; Huang L; Li X; Wang L; Li S; Liu M; Zhang M; Han S; Jiang X; Fu Y; Tian Y; Hou H; Hu Q
    Toxicol In Vitro; 2021 Aug; 74():105173. PubMed ID: 33848590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in Biomarkers of Exposure on Switching From a Conventional Cigarette to the glo Tobacco Heating Product: A Randomized, Controlled Ambulatory Study.
    Gale N; McEwan M; Camacho OM; Hardie G; Murphy J; Proctor CJ
    Nicotine Tob Res; 2021 Feb; 23(3):584-591. PubMed ID: 32776101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The analysis of mainstream smoke emissions of Canadian 'super slim' cigarettes.
    Siu M; Mladjenovic N; Soo E
    Tob Control; 2013 Nov; 22(6):e10. PubMed ID: 22821751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of selected analytes in the emissions of "heat not burn" tobacco products that are relevant to assess human health risks.
    Mallock N; Böss L; Burk R; Danziger M; Welsch T; Hahn H; Trieu HL; Hahn J; Pieper E; Henkler-Stephani F; Hutzler C; Luch A
    Arch Toxicol; 2018 Jun; 92(6):2145-2149. PubMed ID: 29730817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single-blinded, single-centre, controlled study in healthy adult smokers to identify the effects of a reduced toxicant prototype cigarette on biomarkers of exposure and of biological effect versus commercial cigarettes.
    Shepperd CJ; Newland N; Eldridge A; Graff D; Meyer I
    BMC Public Health; 2013 Jul; 13():690. PubMed ID: 23895296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of two novel tobacco blends and filter technologies to reduce the in vitro genotoxicity and cytotoxicity of prototype cigarettes.
    Crooks I; Scott K; Dalrymple A; Dillon D; Meredith C
    Regul Toxicol Pharmacol; 2015 Apr; 71(3):507-14. PubMed ID: 25584437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of number of replicate measurements required to meet cigarette smoke chemistry regulatory requirements measured under Canadian intense smoking conditions.
    Eldridge A; Betson T; Gama MV; Errington G; McAdam K
    Regul Toxicol Pharmacol; 2019 Oct; 107():104402. PubMed ID: 31199996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.